A Study of LY2784544 in Healthy Male Subjects
| Status: | Archived |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | April 2012 |
| End Date: | June 2012 |
| Contact: | This is a single site clinical trial. 1-877-CTLILLY (1-877-285-4559) or |
| Phone: | 1-317-615-4559 |
Disposition of [14C]-LY2784544 Following Oral Administration in Healthy Male Subjects
This is a single dose study of radiolabelled LY2784544 in healthy male subjects to study the
absorption, distribution, metabolism and excretion of LY2784544. This study is for research
purposes only and is not intended to treat any medical condition.
This study is approximately 10 days long, (minimum 5 days, maximum 15 days) not including
screening or follow up. Screening is required within 28 days prior to the first dose of
study drug and follow up is required at least 7 days after discharge from the clinical
research unit.
We found this trial at
1
site
Click here to add this to my saved trials
